High versus standard adalimumab induction dosing regimens in patients with moderately to severely active ulcerative colitis: results from the SERENE-UC induction study

Julian Panés  1     Jean-Frédéric Colombel  2     Geert R. D'Haens  3     Stefan Schreiber  4     Remo Panaccione  5     Laurent Peyrin-Biroulet  6     Edward Loftus     Silvio Danese     Edouard Louis     Alessandro Armuzzi     Marc Ferrante     Harald Vogelsang     Jessica Lefebvre     Thao Doan     Nisha V. Kwatra     Nael M. Mostafa     Wangang Xie     Bidan Huang     Joel Petersson     Jas    
1 Hospital Clinic de Barcelona,Barcelona,Spain
2 Icahn School of Medicine at Mount Sinai,New York,United States
3 AMC Amsterdam Inflammatory Bowel Disease Centre - Academic Medical Center, AMC Amsterdam Inflammator,Amsterdam,Netherlands
4 University Hospital Schleswig-Holstein,Kiel,Germany
5 University of Calgary,Calgary,Canada
6 Nancy Unive

Session
Paradigm shifts in IBD treatment

Conference
UEG Week 2019

Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing